Human NK Cell Education by Inhibitory Receptors for MHC Class I

Immunity

Volumn 25, Issue 2, 2006, Pages 331-342

  Anfossi, Nicolas ^a   André, Pascale ^a   Guia, Sophie ^b,c,d   Falk, Christine S ^e   Roetynck, Sophie ^b,c,d   Stewart, C Andrew ^b,c,d   Breso, Violette ^a   Frassati, Coralie ^f   Reviron, Denis ^f   Middleton, Derek ^g   Romagné, François ^a   Ugolini, Sophie ^b,c,d   Vivier, Eric ^b,c,d,h  

^a INNATE PHARMA   (France)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c INSERM   (France)

^d CNRS   (France)

^e National Research Center for Environment and Health   (Germany)

^f ETABLISSEMENT FRANÇAIS DU SANG   (France)

^g BELFAST CITY HOSPITAL   (United Kingdom)

^h HÔPITAL DE LA CONCEPTION   (France)

Author keywords

CELLIMMUNO

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN RECOGNITION; ARTICLE; CALIBRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

ANIMALS; CELL LINE; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; MICE; PHENOTYPE; RECEPTORS, IMMUNOLOGIC;

EID: 33747101972     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.06.013     Document Type: Article

References (41)

1. Andre P., Spertini O., Guia S., Rihet P., Dignat-George F., Brailly H., Sampol J., Anderson P.J., and Vivier E. Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. Proc. Natl. Acad. Sci. USA 97 (2000) 3400-3405
2. Bakker A.B., Hoek R.M., Cerwenka A., Blom B., Lucian L., McNeil T., Murray R., Phillips L.H., Sedgwick J.D., and Lanier L.L. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13 (2000) 345-353
3. Boyington J.C., and Sun P.D. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol. Immunol. 38 (2002) 1007-1021
4. Bryceson Y.T., March M.E., Barber D.F., Ljunggren H.G., and Long E.O. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J. Exp. Med. 202 (2005) 1001-1012
5. Carrington M., and Martin M.P. The impact of variation at the KIR gene cluster on human disease. Curr. Top. Microbiol. Immunol. 298 (2006) 225-257
6. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., and Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97 (2001) 3146-3151
7. Crum K.A., Logue S.E., Curran M.D., and Middleton D. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 56 (2000) 313-326
8. Daeron M., and Vivier E. Biology of immunoreceptor tyrosine-based inhibition motif-bearing molecules. Curr. Top. Microbiol. Immunol. 244 (1999) 1-12
9. Dorfman J.R., and Raulet D.H. Major histocompatibility complex genes determine natural killer cell tolerance. Eur. J. Immunol. 26 (1996) 151-155
10. Ferlazzo G., and Munz C. NK cell compartments and their activation by dendritic cells. J. Immunol. 172 (2004) 1333-1339
11. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., and Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105 (2005) 4416-4423
12. Fischer A., and Malissen B. Natural and engineered disorders of lymphocyte development. Science 280 (1998) 237-243
13. Furukawa H., Yabe T., Watanabe K., Miyamoto R., Miki A., Akaza T., Tadokoro K., Tohma S., Inoue T., Yamamoto K., and Juji T. Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). Hum. Immunol. 60 (1999) 32-40
14. Hoglund P., Sundback J., Olsson-Alheim M.Y., Johansson M., Salcedo M., Ohlen C., Ljunggren H.G., Sentman C.L., and Karre K. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol. Rev. 155 (1997) 11-28
15. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., French A.R., Sunwoo J.B., Lemieux S., Hansen T.H., and Yokoyama W.M. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436 (2005) 709-713
16. Ljunggren H.G., and Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11 (1990) 237-244
17. Long E.O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17 (1999) 875-904
18. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., and Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5 (2004) 1260-1265
19. Moretta L., and Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 23 (2004) 255-259
20. Moretta A., Bottino C., Mingari M.C., Biassoni R., and Moretta L. What is a natural killer cell?. Nat. Immunol. 3 (2002) 6-8
21. Natarajan K., Dimasi N., Wang J., Mariuzza R.A., and Margulies D.H. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu. Rev. Immunol. 20 (2002) 853-885
22. Olsson M.Y., Kärre K., and Sentman C.L. Altered phenotype and functon of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc. Natl. Acad. Sci. USA 92 (1995) 1649-1653
23. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5 (2005) 201-214
24. Raulet D.H., and Vance R.E. Self-tolerance of natural killer cells. Nat. Rev. Immunol. 6 (2006) 520-531
25. Raulet D.H., Vance R.E., and McMahon C.W. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19 (2001) 291-330
26. Ravetch J.V., and Lanier L.L. Immune inhibitory receptors. Science 290 (2000) 84-89
27. Rubio V., Stuge T.B., Singh N., Betts M.R., Weber J.S., Roederer M., and Lee P.P. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 9 (2003) 1377-1382
28. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
29. Stewart C.A., Laugier-Anfossi F., Vely F., Saulquin X., Riedmuller J., Tisserant A., Gauthier L., Romagne F., Ferracci G., Arosa F.A., et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl. Acad. Sci. USA 102 (2005) 13224-13229
30. Tay C.H., Welsh R.M., and Brutkiewicz R.R. NK cell response to viral infections in beta 2-microglobulin-deficient mice. J. Immunol. 154 (1995) 780-789
31. Tomasello E., Desmoulins P.O., Chemin K., Guia S., Cremer H., Ortaldo J., Love P., Kaiserlian D., and Vivier E. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 13 (2000) 355-364
32. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 15 (2001) 363-374
33. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., Phillips J.H., Lanier L.L., and Parham P. Functionally and structurally distinct NK cell receptor repertories in the peripheral blood of two human donors. Immunity 7 (1997) 739-751
34. Vitale M., Zimmer J., Castriconi R., Hanau D., Donato L., Bottino C., Moretta L., de la Salle H., and Moretta A. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood 99 (2002) 1723-1729
35. Vivier E., Nunes J.A., and Vely F. Natural killer cell signaling pathways. Science 306 (2004) 1517-1519
36. Williams F., Meenagh A., Patterson C., and Middleton D. Molecular diversity of the HLA-C gene identified in a caucasian population. Hum. Immunol. 63 (2002) 602-613
37. Wolint P., Betts M.R., Koup R.A., and Oxenius A. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J. Exp. Med. 199 (2004) 925-936
38. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., and Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 203 (2006) 633-645
39. Yokoyama W.M., and Kim S. How do natural killer cells find self to achieve tolerance?. Immunity 24 (2006) 249-257
40. Yokoyama W.M., and Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3 (2003) 304-316
41. Zimmer J., Donato L., Hanau D., Cazenave J.P., Tongio M.M., Moretta A., and Salle H. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J. Exp. Med. 187 (1998) 117-122